Andras Furedi

Budapest, BU, Hungary

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Reframing cancer drug resistance: transporters, persister cells, senescence, and emerging therapeutic strategies.

Reframing cancer drug resistance: transporters, persister cells, senescence, and emerging therapeutic strategies.

Journal: Magyar onkologia
Published: April 17, 2026

Algorithm-assisted individualized therapy design improves survival in a mouse model of triple-negative breast cancer.

Algorithm-assisted individualized therapy design improves survival in a mouse model of triple-negative breast cancer.

Journal: NPJ precision oncology
Published: October 25, 2025

Fluorescent properties of FDA-approved anti-leukemia drugs.

Fluorescent properties of FDA-approved anti-leukemia drugs.

Journal: Biomedical optics express
Published: October 09, 2025

Safe delivery of a highly toxic anthracycline derivative through liposomal nanoformulation achieves complete cancer regression.

Safe delivery of a highly toxic anthracycline derivative through liposomal nanoformulation achieves complete cancer regression.

Journal: Molecular cancer
Published: March 31, 2025

Therapy-induced senescence is a transient drug resistance mechanism in breast cancer.

Therapy-induced senescence is a transient drug resistance mechanism in breast cancer.

Journal: Molecular cancer
Published: January 24, 2025

Mesenchymal Stem Cells Increase Drug Tolerance of A431 Cells Only in 3D Spheroids, Not in 2D Co-Cultures.

Mesenchymal Stem Cells Increase Drug Tolerance of A431 Cells Only in 3D Spheroids, Not in 2D Co-Cultures.

Journal: International journal of molecular sciences
Published: February 17, 2024

Reproducibility analysis of bioimpedance-based self-developed live cell assays.

Reproducibility analysis of bioimpedance-based self-developed live cell assays.

Journal: Scientific reports
Published: July 18, 2023

Effective targeting of breast cancer by the inhibition of P-glycoprotein mediated removal of toxic lipid peroxidation byproducts from drug tolerant persister cells.

Effective targeting of breast cancer by the inhibition of P-glycoprotein mediated removal of toxic lipid peroxidation byproducts from drug tolerant persister cells.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: May 19, 2023

Comparison of Different Clinical Chemotherapeutical Agents' Toxicity and Cell Response on Mesenchymal Stem Cells and Cancer Cells.

Comparison of Different Clinical Chemotherapeutical Agents' Toxicity and Cell Response on Mesenchymal Stem Cells and Cancer Cells.

Journal: Cells
Published: July 07, 2022

P-Glycoprotein Activity at Diagnosis Does Not Predict Therapy Outcome and Survival in Canine B-Cell Lymphoma.

P-Glycoprotein Activity at Diagnosis Does Not Predict Therapy Outcome and Survival in Canine B-Cell Lymphoma.

Journal: Cancers
Published: May 30, 2022

Mesenchymal-Stromal Cell-like Melanoma-Associated Fibroblasts Increase IL-10 Production by Macrophages in a Cyclooxygenase/Indoleamine 2,3-Dioxygenase-Dependent Manner.

Mesenchymal-Stromal Cell-like Melanoma-Associated Fibroblasts Increase IL-10 Production by Macrophages in a Cyclooxygenase/Indoleamine 2,3-Dioxygenase-Dependent Manner.

Journal: Cancers
Published: September 29, 2021

Mathematical and computational methods to model chemotherapy- induced resistance

Mathematical and computational methods to model chemotherapy- induced resistance

Journal: Magyar onkologia
Published: April 16, 2021
Showing 1-12 of 24

Last Updated: 09/26/2026